Vaccines
Process Development and Application Expertise

Viral Vectors & DNA/RNA

Vaccines & Viral Therapy Process:

Biopharmaceutical
Applications Guide

Innovative technologies and class leading services, to help you accelerate process development and achieve performance goals.

  • Speed to clinic
  • Predictable scale up
  • Boost upstream productivity
  • Robust impurity removal
  • Maximize downstream recovery
  • Patient safety and regulatory compliance
Upstream
Downstream
Formulation

Upstream

Upstream Process Scale Up

Featured Solution

Watch our webinar:

Predictable scale up from a research stage process to achieve reliable, and consistent virus production is key to clinical readiness.


Associated Products:

Upstream

Boost Upstream Productivity

Watch our webinar:

  • Viral Safety for Novel Biological Therapies
    Regulatory guidance advocates virus control via selection and testing of source materials, removal/inactivation during the production process, testing for adventitious viruses at appropriate stages.

Viral vector gene therapy products present a unique challenge for viral safety. Careful selection and testing of raw material, inclusion of viral reduction steps and the use of upstream barriers can result in products that are safe from adventitious viruses.



Associated Products: